{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T20:57:49Z","timestamp":1788209869071,"version":"build-2803163510"},"reference-count":27,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2012,1,16]],"date-time":"2012-01-16T00:00:00Z","timestamp":1326672000000},"content-version":"vor","delay-in-days":3182,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2003,5]]},"abstract":"<jats:p>\n                    Morbidity and mortality due to certain bacterial pathogens have not declined despite the availability of effective antimicrobial treatments.\n                    <jats:italic>Staphylococcus aureus<\/jats:italic>\n                    and\n                    <jats:italic>Streptococcus pyogenes<\/jats:italic>\n                    cause a number of serious infections, such as necrotizing fasciitis and toxic shock syndrome, which are associated with the release of bacterial toxins. Animal studies have demonstrated clindamycin, a protein synthesis inhibitor, to be more effective in treating these severe infections than other more susceptible antimicrobial treatments. Linezolid, another protein synthesis inhibitor, also has shown efficacy in in vitro studies. Human trials to validate the effects of antibiotic therapies on bacterial virulence have not been performed. Future animal and human studies are needed to help elucidate the immunomodulatory mechanisms of protein synthesis inhibitors in order to optimize antimicrobial treatment and decrease the morbidity and mortality associated with severe bacterial infections.\n                  <\/jats:p>","DOI":"10.1592\/phco.23.5.638.32191","type":"journal-article","created":{"date-parts":[[2004,5,11]],"date-time":"2004-05-11T11:14:20Z","timestamp":1084274060000},"page":"638-642","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Targeting Bacterial Virulence: The Role of Protein Synthesis Inhibitors in Severe Infections"],"prefix":"10.1002","volume":"23","author":[{"given":"Elizabeth A.","family":"Coyle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,1,16]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0094-0143(05)70211-1"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0732-8893(92)90129-H"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110152"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/158.1.23"},{"issue":"3","key":"e_1_2_1_6_2","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1128\/AAC.43.3.616","article-title":"Clindamycin suppresses endotoxin released by ceftazidime\u2010treated Escherichia coli O55:B5 and subsequent production of tumor necrosis factor alpha and interleukin\u20101","volume":"43","author":"Kishi K","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.9.2638-2642.2001"},{"key":"e_1_2_1_8_2","first-page":"574","volume-title":"Resurgent group A streptococcal disease: lessons learned and the task ahead [abstr]","author":"Bisno AL.","year":"1998"},{"issue":"3","key":"e_1_2_1_9_2","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1128\/iai.64.3.861-869.1996","article-title":"Analysis of the superantigenic activity of mutant and allelic forms of streptococcal pyrogenic exotoxin A","volume":"64","author":"Kline JB","year":"1996","journal-title":"Infect Immun"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/173.6.1399"},{"key":"e_1_2_1_11_2","first-page":"576","volume-title":"Invasive group A streptococcal infection in Ontario children [abstr]","author":"Laupland K","year":"1998"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.13.3.470"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/36.2.283"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-695X.1999.tb01232.x"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5520(05)70081-7"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.13.1.16-34.2000"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02786471"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92752-F"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.42.9.935"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.3109\/10408419009105728"},{"issue":"11","key":"e_1_2_1_21_2","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1128\/AAC.42.11.2817","article-title":"Effects of subinhibitory concentrations of antibiotics on alpha\u2010toxin (hla) gene expression of methicillin\u2010sensitive and methicillin\u2010resistant Staphylococcus aureus isolates","volume":"42","author":"Ohlsen K","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkf192"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/167.6.1401"},{"issue":"8","key":"e_1_2_1_24_2","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1128\/AAC.41.8.1682","article-title":"Combination of flucloxacillin and gentamicin inhibits toxic shock syndrome toxin 1 production by Staphylococcus aureus in both logarithmic and stationary phases of growth","volume":"41","author":"Langevelde P","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_1_25_2","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1128\/AAC.42.5.1266","article-title":"In vitro antimicrobial effects of various combinations of penicillin and clindamycin against four strains of Streptococcus pyogenes.","volume":"42","author":"Stevens DL","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.6.587"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1998.tb03109.x"},{"key":"e_1_2_1_28_2","first-page":"38","volume-title":"Influence of linezolid, penicillin, and clindamycin, alone and in combination on streptococcal pyrogenic exotoxin A (SPE A) release [abstr]","author":"Coyle EA","year":"2001"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1592%2Fphco.23.5.638.32191","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1592\/phco.23.5.638.32191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:23:28Z","timestamp":1761067408000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1592\/phco.23.5.638.32191"}},"subtitle":["Insights from the Society of Infectious Diseases Pharmacists"],"short-title":[],"issued":{"date-parts":[[2003,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["10.1592\/phco.23.5.638.32191"],"URL":"https:\/\/doi.org\/10.1592\/phco.23.5.638.32191","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5]]},"assertion":[{"value":"2012-01-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}